During the past decade, UMHAT 'Sveta Anna' AD conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT 'Sveta Anna' AD" #1 sponsor was "Galapagos NV" with 2 trials, followed by "Takeda" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "4Living Biotech" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT 'Sveta Anna' AD" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT 'Sveta Anna' AD" are "Cardiovascular Diseases" (2 trials), "Colitis, Ulcerative" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "UMHAT 'Sveta Anna' AD" in a lesser frequency.

Most popular intervention types in "UMHAT 'Sveta Anna' AD" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ralinepag" (2 trials), "1.25 g PA21 (250 mg iron)" (1 trials), "10.0 g PA21 (2,000 mg iron)" (1 trials) and "12.5 g PA21 (2,500 mg iron)" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT 'Sveta Anna' AD" are 16 trials for "All" genders.

Currently, there are NaN active trials in "UMHAT 'Sveta Anna' AD". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in UMHAT 'Sveta Anna' AD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT 'Sveta Anna' AD, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".